| AMCZX | FSMAX | AMCZX / FSMAX | |
| Total Expense Ratio | 0.79 | 0.04 | 2,257% |
| Annual Report Gross Expense Ratio | 0.92 | 0.04 | 2,629% |
| Fund Existence | 11 years | 15 years | - |
| Gain YTD | 2.940 | 13.370 | 22% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 500000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 290M | 40.1B | 1% |
| Annual Yield % from dividends | 0.00 | 0.49 | - |
| Returns for 1 year | 0.47 | 13.05 | 4% |
| Returns for 3 years | 54.45 | 63.92 | 85% |
| Returns for 5 years | -19.78 | 32.77 | -60% |
| Returns for 10 years | 90.15 | 133.42 | 68% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| CNAV | 39.37 | 0.52 | +1.35% |
| Mohr Company Nav ETF | |||
| MSSM | 58.61 | 0.43 | +0.73% |
| Morgan Stanley Pathway Sm-Md Cp Eq ETF | |||
| ITWO | 44.53 | 0.22 | +0.49% |
| ProShares Russell 2000 High Income ETF | |||
| XBI | 156.20 | -0.62 | -0.40% |
| State Street® SPDR® S&P® Biotech ETF | |||
| KMLI | 9.89 | -0.09 | -0.87% |
| KraneShares 2x Long MELI Daily ETF | |||